Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Christopher  Mann

Christopher Mann

Scientific & Regulatory Affairs Associate Director, Asphalion

PhD in Biomedicine.

Academic research in gene therapy, regeneration and muscular dystrophy, diabetes.

He has published numerous original research papers and review articles in peer reviewed journals.

Expert in medical and scientific writing for Biosimilars, Innovative, Biological, Biotechnological, and Advanced Therapy Medicinal Products, including gene and somatic cell therapies.

Currently working in medical writing for Paediatric Investigation Plans, Scientific Advice/Pre-IND meetings and Centralized Procedures.

Experience in Biosimilars CP writing Clinical and Pre-Clinical.

World wide experience in Biosimilars Gap Analysis and writing

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd